James Xue

James Xue is the founder of CANbridge Life Sciences Ltd.
(2012) and CANbridge Pharmaceuticals Inc. (2018), where he holds the titles of Chairman, President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of CANbridge Consulting LLC.
Currently, he holds the position of President, Secretary & Director at Canbridge Pharmaceuticals, Inc. (United States), Deputy Director General at China Alliance For Rare Diseases, Deputy Director at Shanghai Foundation For Rare Disease, Member-Leadership Council at Peking University Health Science Center, Member at The BayHelix Group, and Member-Leadership Council at the University of Michigan Medical School.
His former position was as General Manager-Genzyme China at Genzyme Corp.
He received his doctorate from Brown University in 1997, his graduate degree from the University of California in 1998, his MBA from the University of Virginia Darden School of Business in 2002, and his undergraduate degree from Peking University School of Pharmaceutical Sciences in 1992.